홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ACRS
#2714
Aclaris Therapeutics, Inc.
2.8
7
-8.01%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-8.01%
월간 변동
-26.41%
6달 변화
+56.83%
년간 변동율
+50.26%
이전 종가
3.1
2
Open
2.8
7
Bid
Ask
Low
2.8
7
High
2.8
7
양
58
마켓
주식
헬스케어
ACRS
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
51.8 M
61.28 M
66.69 M
70.93 M
107.92 M
120.6 M
—
Valuation ratios
Enterprise value
313.11 M
863.59 M
959.79 M
34.59 M
243.07 M
343.03 M
787.37 M
Price to earnings ratio
—
-9.09
-11.33
-0.83
-1.45
-5.68
-8.75
Price to sales ratio
—
122
33.03
2.35
10.24
—
—
Price to cash flow ratio
—
15.82
14.55
0.94
9.55
7.83
-295.07
Price to book ratio
—
4.18
4.97
0.47
1.23
3.58
4.4
Enterprise value to EBITDA ratio
-17.26
-43.24
728.21
-2.55
-29.76
—
—
Profitability ratios
Return on assets %
0.72
0.36
0.34
0.45
0.6
0.4
0.36
Return on equity %
1.35
0.46
0.44
0.56
0.85
0.63
0.54
Return on invested capital %
1 118.27
1 086.25
958.37
798.73
657.83
210.26
190.61
Gross margin %
20.81
30.29
86.48
89.05
85.09
73.28
278.85
Operating margin %
785.44
1 327.07
302.01
311.55
758.18
975.91
4 554.14
EBITDA margin %
-279.93
-295.39
4.43
-43.39
-43.63
-201.67
-997.97
Net margin %
787.03
1 343.96
292.11
283.15
705.48
829.58
3 876.59
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
3.87
8.94
10.55
4.16
3.99
3.36
16.23
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.08
0.04
0.12
0.14
0.09
0.04
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.15
0.04
—
—
—
—
—
Long term debt to total equity ratio
0.28
0.05
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
0.92
1.04
1.12
0.26
0.38
0.38
EBIT per share
—
-0.37
0.01
-0.21
-0.12
-0.13
-0.13
EBITDA per share
—
-0.35
0.02
-0.19
-0.11
-0.13
-0.13
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
3.98
3.52
2.61
2.64
1.24
5.63
Net current asset value per share
—
3.61
3.55
1.85
1.63
0.79
3.35
Tangible book value per share
—
3.35
2.92
2.25
2.01
0.84
4.07
Working capital per share
—
3.21
3.21
1.4
1.22
0.55
2.51
Book value per share
—
3.48
3.03
2.25
2.01
0.84
4.07
뉴스
스티펠, Aclaris Therapeutics 목표 주가 3달러로 상향
Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Aclaris Therapeutics Inc Q4 실적, 수익 에상치보다 저조
Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates
Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates
Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates
Aclaris, 천식 환자 대상 ATI-052 1b상 임상시험 개시
Aclaris starts phase 1b trial of ATI-052 in asthma patients
크레이그-할럼, Aclaris Therapeutics에 ’매수’ 등급 제시
Craig-Hallum initiates coverage on Aclaris Therapeutics stock with Buy rating
화이자 경쟁 약물보다 뛰어난 아클라리스, H.C. Wainwright ’매수’ 등급 재확인